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INTRODUCTION
Inflammatory bowel diseases (IBD), including ulcerative coli-
tis (UC) and Crohn’s disease (CD), are chronic idiopathic in-
flammatory disorders of the gastrointestinal tract. In the last 
20th century, IBD was regarded as a Western disease in North 
America and Europe, not in South America, Eastern Europe, 
Asia, or Africa. However, the incidence and prevalence of IBD 
have been increased globally in the 21st century.1 Although 
still lower than that in Western countries, cases of IBD in Asia 
are rising.2-6 Research has shown that genetic susceptibility and 
environmental triggers can modulate immunologic responses 
and that microbial composition in the gut can contribute to in-
creases in IBD development.7 The increased disease burden of 
IBD in Asia could be associated with changes in environmental 
factors, such as improvement in hygiene, socioeconomic sta-
tus changes, and Westernized diets. We will describe the latest 
trends in the incidence and prevalence of IBD in Asia. 
EPIDEMIOLOGICAL RESEARCH METHODS
Cross-sectional and cohort studies have been performed to 
investigate the epidemiology of IBD. Therein, the selection of 
study groups is important to minimize selection bias. Although 
a hospital-based study could minimize the recall of informa-
tion, the study population may not be representative of the true 
population. To overcome generalizability, a population-based 
study can be performed to minimize heterogeneity. This ap-
proach may better represent a particular geographic area and 
reflect important information about the population-based char-
acteristics of IBD: this can be valuable because a population of 
IBD patients in a given geographic area could present a unique 
disease phenotype. However, it can be difficult to accurately 
identify case groups among the entire population, and doing 
so may require tremendous effort and cost. Meanwhile, big 
data studies using nationwide or state wide databases could in-
form the epidemiology of IBD for an entire population, whether 
that be a single nation or worldwide. Big data studies, however, 
are limited to retrospective population studies, which are not 
available to obtain detailed information about disease courses 
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or medications. 
Recent epidemiological studies have demonstrated rising 
disease burden for IBD in developing countries, including Asia 
countries. Since individual epidemiological studies have their 
own strengths and limitations, it is necessary to select an appro-
priate method with which to interpret them according to the 
subject and purpose of the study. In this review, we will cover 
previous epidemiologic studies of IBD in Asia, including hospi-
tal-based, population-based, and big data-based studies.
EPIDEMIOLOGY OF IBD IN ASIAN 
MIGRANTS
Research evaluating changes in IBD epidemiology between 
first- and second-generation immigrants has highlighted the 
importance of environmental factors affecting the develop-
ment of IBD. The research on IBD epidemiology in  asian mi-
grants is summarized in Table 1. The first study on the impact of 
migration on IBD focused on Bangladeshi immigrants who set-
tled in Tower Hamlets, East London. The incidence of UC 
among Bangladeshi residents in the London Borough of Tower 
Hamlets from 1972 to 1989 was very low (1.8 cases/105/year).8 
The incidence of UC among Bangladeshi residents in Tower 
Hamlets increased from 2.4 cases/105/year in 1981–1989 to 8.2 
cases/105/year in 1997–2001.9 The incidence of CD among 
Bangladeshis residents in Tower Hamlets also increased grad-
ually throughout the 1970s (1.2 cases/105/year), 1980s (2.3 
cases/105/year), and 1990s (7.3 cases/105/year).9,10 Bangla-
deshis immigrants had a higher incidence of IBD than the lo-
cal population, thus supporting the significant role of environ-
mental factors in the development of IBD. 
Another study related to South Asian migrants addressed 
Indian, Gujarati or Punjabi, immigrants who settled in Leices-
ter city. The incidence of UC in the South Asian community in 
Leicester city was high from 1991 to 1994, even higher than that 
in the European community (17.2 cases/105/year vs. 7.0 cas-
es/105/year, respectively).11 The prevalence of UC in the South 
Asian community in Leicester city was also higher than that in 
Europeans (135 cases/105/year vs. 90.8 cases/105/year, respec-
tively).12 The risk of UC in this particular community was even 
higher than that for individuals of European descent living in 
the same area, suggesting that the pattern of UC followed an 
indigenous population after only one generation. Meanwhile, 
a recent study revealed three novel human leucocyte antigen 
(HLA)-independent single-nucleotide polymorphisms (SNPs) 
for UC in the north Indian population,13 support the notion that 
the genetic background in a certain ethnic group can contrib-
ute to the development of IBD. In a recent epidemiologic study 
in 2016, the incidence of UC in an Indian group was higher 
(20.5 cases/105/year) than that in a Pakistani group (11.2 cas-
es/105/year) and white European group (7.5 cases/105/year) 
in the multi-ethic United Kingdom, although the study popu-
lation was predominantly born in the United Kingdom.14 Inter-
estingly, the prevalence of CD in the same South Asian com-
munity in Leicester city was lower than that in Europeans (33.2 
cases/105/year vs. 75.8 cases/105/year, respectively).12 Indeed, 
research supports a difference between UC and CD epidemi-
ology in immigrants: early life dysbiosis events, such as caesar-
ean section, increased hygiene, and repeated antibiotics, are re-
lated to the risk of CD, whereas late dysbiosis events are related 
to the risk of UC.15 Further studies of intestinal microbiota and 
environmental factors will be needed to confirm this hypothe-
sis. In summary, north Indian migrants in Leister city face a 
higher risk of UC, but not CD, compared to European descents. 
Further studies investigating the interplay among several factors, 
including intestinal microbiota, diet, and other environmental 
causes, may be crucial to explain this. 
Canada also has a large South Asian population. The inci-
dence of IBD of immigrants in Ontario, Canada was lower than 
that of nonimmigrants from 1994 to 2009 (7.3 cases/105/year 
vs. 23.9 cases/105/year).16 Younger age at immigration increased 
the risk of IBD immigrants. Also, children of immigrants from 
the Middle East/North Africa, South Asia, Sub-Saharan Africa, 
and North America/Western Europe had a similar risk of IBD 
as children of nonimmigrants; however, the incidence remained 
lower among children of immigrants from other regions. The 
early exposure to high risk environment with specific genetic 
background could increase the risk IBD. 
All of these results support the role of environmental factors 
in IBD development. Immigration could alter the gut microbi-
ome composition. It is known that changes in diet have the 
greatest effect on changes in the composition of intestinal mi-
crobes. The microbiome of Thailand immigrants who settled 
in the United States experience a loss of gut microbiome diver-
sity and shifts from Prevotella dominance to Bacteroides dom-
inance.17 Immigration-related microbiome changes started 
upon arrival to the United States and increased with a longer 
duration of residence in the United States and across genera-
tions. Future research should focus on identifying and modi-
fying environmental risk factors to reduce the risk of IBD. 
EPIDEMIOLOGY OF IBD IN INDIGENOUS 
ASIANS
East Asia
The research on IBD epidemiology in indigenous asian is sum-
marized in Table 2. In Japan, the prevalence rates of UC and 
CD in the nationwide registration system were 7.85 cases/105/
year and 1.86 cases/105/year, respectively, in 1985.18 The inci-
dence rate of UC was very low in 1990 (0.36–0.40 cases/105/
year).19 The prevalence rates of UC and CD in a survey of na-
tionwide hospitals were also low in 1991 (18.1 cases/105/year 
and 5.9/105/year, respectively).20 The prevalence rates of UC 
and CD in the nationwide registration system in Japan in-
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creased by 2005 (63.6 cases/105/year and 21.2/105/year, re-
spectively).21 In a recent study using the same method as the 
previous study in 1991, the prevalence rates of UC and CD mark-
edly increased in 2014 (172.9 cases/105/year and 55.6/105/
year, respectively).22 Based on information provided on the 
website for the Japan Intractable Diseases Information Center, 
143733 and 170781 patients were diagnosed with UC in 2014 
and 2016, respectively. For CD, 36418 and 40855 patients were 
diagnosed in 2014 and 2016 respectively. Japan has the highest 
incidence and prevalence rates of IBD in East Asia. 
In South Korea, the incidence rate of UC in a particular ur-
ban area of Seoul increased over time (0.20 cases/105/year, 
1986–1988; 1.23 cases/105/year, 1995–1997; 3.08 cases/105/
year, 2001–2005; 5.82 cases/105/year, 2011–2015).23-25 The inci-
dence rate of CD in the same district also increased (0.05 cas-
es/105/year, 1986–1990; 1.34 cases/105/year, 2001–2005; 2.44 
cases/105/year, 2011–2015).23,25 The incidence rates of UC and 
CD in a nationwide registration system from 2006 to 2014 were 
reported at 4.6–5.0 cases/105/year and 2.8–3.2 cases/105/year, 
respectively.26,27 The prevalence rates of UC (30.87 cases/105/
year, 2005; 41.4 cases/105/year, 2009; 66.0 cases/105/year, 2016) 
and CD (11.24 cases/105/year, 2005; 16.0 cases/105/year, 2009; 
29.6 cases/105/year, 2016) in South Korea were also increas-
ing.24,28 The epidemiology of IBD in South Korea is still lower 
than that in Western countries, but has increased over the past 
few decades. South Korea has the second highest IBD incidence 
and prevalence rate in East Asia, and this appears to be strong-
ly associated with improvements in socioeconomic status and 
accompanying changes in environmental factors.
In Hong-Kong, the incidence rates of UC at a single hospital 
were reported as 0.34 cases/105/year in 1997 and 0.37 cases/105/
year in 2006, indicating no definite increase over time.29 The 
prevalence rates for UC in the same study were reported at 2.26 
cases/105/year in 1997 and 6.3 cases/105/year in 2006. After 
that study, the incidence rate and prevalence rate of UC were 
reported at 2.1 cases/105/year in 1997 and 26.5 cases/105/year 
in 2006, respectively.30 In a recent study of a territory-wide pop-
ulation-based registry, the incidence rate of UC significantly in-
creased with time (0.09 cases/105/year, 1985; 1.51 cases/105/
year, 2014).31 The prevalence rate of UC also increased (0.49 
cases/105/year, 1985; 21.14 cases/105/year, 2014).31 The inci-
dence (0.4 cases/105/year, 1990–1992; 1.0 cases/105/year, 1999–
2001; 1.46 cases/105/year, 2014) and prevalence (0.49 cases/105/
year, 1991; 2.7 cases/105/year, 2006; 14.17 cases/105/year, 2011–
2014) of CD increased in the Hong Kong Chinese popula-
tion.31-33 The incidence and prevalence of IBD in Hong Kong 
are lower than those in the West, but comparable to those in 
other East Asian countries. In a population-based study per-
formed in 2011, the IBD incidence rate for Mainland China 
was 0.52–3.44 cases/105/year; that for Hong Kong was 3.06 cas-
es/105/year; and that for Macau was 2.20 cases/105/year. 34
In Taiwan, the incidence and prevalence rates of IBD were 
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Kong.35,36 The incidence (0.97 cases/105/year, 2001–2005; 1.16 
cases/105/year, 2006–2010; 1.18 cases/105/year, 2011–2015) 
and prevalence rates (4.54 cases/105/year, 2001–2005; 9.39 cas-
es/105/year, 2006–2010; 14.40 cases/105/year, 2011–2015) of 
UC in Taiwan increased steadily from 2001 to 2015.37 The inci-
dence (0.18 cases/105/year, 2001–2005; 0.22 cases/105/year, 
2006–2010; 0.39 cases/105/year, 2011–2015) and prevalence 
rates (0.84 cases/105/year, 2001–2005; 1.71 cases/105/year, 2006– 
2010; 3.04 cases/105/year, 2011–2015) of CD in Taiwan also in-
creased steadily from 2001 to 2015.37
In Singapore, the majority residents were Chinese (78.7%) 
in 1990; 12.8% were Malays; and 7.6% were Indians. The prev-
alence rates of UC and CD in Singapore between 1985 and 
1996 were 6.0 cases/105/year and 3.6 cases/105/year, respec-
tively.38 Indians had a 2.9-fold higher risk of UC than Chinese in 
this study, which further implicated ethnic differences in IBD 
development. 
In the Asia-Pacific Crohn’s Colitis Epidemiology Study in 
2011, the incidence of UC and CD in Malaysia was 0.59 cas-
es/105/year and 0.24 cases/105/year, respectively.34 In Malay-
sia, the majority of residents of Kinta Valley from 2011 to 2013 
were Chinese (43%); 39% were Malays; and 14% were Indians. 
The incidence of UC and CD in Malaysia between 2011 and 
2013 was 0.46 cases/105/year and 0.2 cases/105/year, respective-
ly.39 The prevalence of UC and CD in Malaysia between 2011 
and 2013 was 6.67 cases/105/year and 2.17 cases/105/year, re-
spectively.39 Both incidence and prevalence rates in Indians 
were higher than those in Chinese and Malays. Although, the 
incidence and prevalence rates of IBD are low in Malaysia, they 
have increased over the past two decades. 
In Thailand, the incidence of UC and CD was reported at 
0.35–0.36 cases/105/year and 0.28–0.30 cases/105/year in the 
Asia-Pacific Crohn’s Colitis Epidemiology Study in 2011. The 
prevalence of UC and CD in a single institution of Bangkok, 
Thailand during 2005–2010 was significantly lower in Asian in-
dividuals than Middle Eastern and Caucasian individuals.40,41
In summary, the incidence and prevalence rates of IBD in 
East Asia are lower than those in Western countries, but have 
steadily increased over time. A north-south gradient, with an 
increasing trend reported in Northern countries, compared to 
Southern countries in Europe, could be a global phenome-
non.42,43 Environmental factors, such high temperature, latitude, 
and precipitation, could change microbial compositions and 
affect the development of IBD.44 There is a hypothesis that 
summer temperature could be associated with a protective ef-
fect against IBD by affecting the richness of microbiome.44 In 
addition to climate, various other factors, such as dietary hab-
its and socioeconomic status, have also been shown to be as-
sociated with the incidence and prevalence of IBD. The epide-
miologic studies in Asia, especially in East Asia, have several 
limitations, mainly due to their hospital-based approach. In ad-
dition, some studies were based on small regions. Accordingly, 





































































































































































































































































































































































































































































































































































































































































South Asia is comprised of India, Pakistan, Bangladesh, Ne-
pal, and Sri Lanka. There are only two available studies on the 
incidence and prevalence of IBD in this region, and these were 
performed in Northern India, not across the whole country. 
The prevalence rate of UC in Northern India in 1986 was 42.8 
cases/105/year.45 The prevalence rate of UC in Northern India in 
1999 was 44.3 cases/105/year, and the incidence rate was 6.02 
cases/105/year.46 The incidence and prevalence of UC in India 
are highest among Asia countries, although they are much 
lower than those in Western countries.47,48 Although there was 
no study on the incidence and prevalence of CD in India, in-
direct estimates of CD burden have risen over the years.49,50 
Recently, Kedia and Ahuja51 predicted that the overall disease 
burden was highest in India among six countries in Asia, North 
America, and Europe. Infectious diseases, including intestinal 
tuberculosis, remain endemic in India, and there are many 
other infectious mimics of IBD that can lead to misdiagnosis 
and diagnostic delay in India.49 However, there are many ef-
forts to improve awareness about IBD and to improve access 
to medical services to differentiate acute infectious colitis 
from IBD.52 Nevertheless, more than 300000 Indians are esti-
mated to have CD, and 1.1 million people have UC in India. 
Because of the large population of India, with more than 120 
million, the total IBD burden of India could be highest in the 
world. Because research in South Asia is very scarce, epide-
miologic studies are needed. Since Indians are ethnically in-
cluded as Europeans, similar incidence and prevalence rates 
could be possible; however, it seems that incidence and prev-
alence rates are still lower due to differences in climate, hy-
giene, and food intake.
West Asia
In Lebanon, the incidence rates of UC and CD were reported 
at 4.1 cases/105/year and 1.4 cases/105/year, respectively, on a 
cohort based on university-based healthy program from 2000 
to 2004.53 In Saudi Arabia, the incidence of CD at a university 
hospital in Riyadh increased gradually through the 1980s (0.32 
cases/105/year) and 1990s (1.66 cases/105/year).54 In a multi-
center study of Saudi Arabian children, the incidence rate of 
UC increased gradually from 2003–2007 (0.16 cases/105/year) 
to 2008–2012 (0.24 cases/105/year).55 The incidence of CD also 
increased from 2003–2007 (0.19 cases/105/year) to 2008–2012 
(0.35 cases/105/year).55 In Kuwait, the incidence of UC and CD 
were reported to be 2.27 cases/105/year and 0.45 cases/105/
year, respectively, from 1977–1982.56 The incidence of UC in 
Fig. 1. Incidence and prevalence rate of inflammatory bowel disease in Asian countries. (A) Incidence rate (per 100000 population) and (B) prevalence 
rate (per 100000 population) of ulcerative colitis in the 21st century. (C) Incidence rate (per 100000 population) and (D) prevalence rate (per 100000 popula-
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Kuwait increased from 1985 to 1990 (2.8 cases/105/year).57 In 
Oman, the incidence rate of UC was 1.35 cases/105/year in 
1980s.58 In summary, the incidence and prevalence of IBD in 
Arab countries appear to be relatively low, although there is an 
increasing trend. 
In Israel, the incidence of UC and CD in the Jewish popula-
tion was reported at 3.79–5.8 cases/105/year and 2.1–5.2 cas-
es/105/year, respectively, in the 1980s and 1990s.59-64 The inci-
dence and prevalence of IBD in the Jewish population also 
increased in Israel.59,62,63 Interestingly, the prevalence of IBD in 
the Israel Arab population, who represent 20% of the total 
population, was lower than that in the Israel Jewish popula-
tion.59,65 The incidence and prevalence of IBD in an Arab pop-
ulation were lower than those in an Jewish population from 
2003 to 2008, although there has been a rapid increase in CD 
in the Arab population.66 Also, the incidence and prevalence of 
IBD in the Arab population in Israel are relatively higher than 
those in other Arab countries.66 Various environmental factors, 
ethnic factors, and microbial factors might affect these epide-
miologic shifts in these areas.
In Iran, the incidence of UC and CD were reported at 2.70–
5.32 cases/105/year and 0.16–0.88 cases/105/year, respectively, 
in 1990–2012.67-69 An epidemiologic study in Iran, a rapidly 
developing Middle Eastern country, demonstrated a rapid in-
crease in IBD in parallel with other developing countries. From 
an ethnic point of view, West Asian populations are similar to 
the European population, compared to East Asian populations. 
Therefore, the incidence and prevalence in West Asia could in-
crease in the future. 
In summary, the incidence and prevalence of IBD in East, 
South, and West Asia remain lower than those in Western coun-
tries, including America, Europe, and Australia. Nevertheless, 
the overall incidence and prevalence of IBD have consistently 
increased. Among Asian countries, India has had a higher in-
cidence rate than other countries. The incidence and preva-
lence of IBD in Asia countries during the 21st century strati-
fied from low to high (per 1000000) are presented in Fig. 1. 
Immigrant studies support the role of environmental factors 
in IBD development. Also, studies comparing various popula-
tion groups support the contribution of ethnic factors to the de-
velopment of IBD. From epidemiologic studies, we could de-
duce that various factors, including geographic factors, ethnic 
factors, and environmental factors, may be simultaneously as-
sociated with the pathogenesis of IBD.
CONCLUSIONS
Epidemiologic studies of IBD have been conducted in Asian 
countries, and the incidence and prevalence of IBD in Asia 
have increased over time. Asia, as a continent, has the most IBD 
patients in the world, and the observed increase in IBD among 
Asian countries is likely associated with environmental factors 
related to IBD pathogenesis, since genetic factors would not 
change over only a few decades. Studying the epidemiology of 
IBD in Asia may unravel the etiopathogenesis and risk factors 
for IBD. Also, research intro genetic susceptibility and ethnic 
differences may provide insights into possible genetic etiolog-
ical factors for IBD. Continued research and collection of inci-
dence and prevalence data are warranted. Also, a large scale 
study through which Asian countries collaborate together to 
conduct comprehensive epidemiological and genetic studies 
could prove beneficial.
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